Ati cautat: corp medical

Protocol terapeutic: B06AC01 – DCI INHIBITOR DE ESTERAZĂ C1, UMANĂ (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: B02BD02 – DCI RURIOCTOCOG ALFA PEGOL (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: B01AX07 – DCI CAPLACIZUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: B01AF03 – DCI EDOXABANUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: A16AB15 – DCI VELMANAZA ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: A16AB03 – DCI AGALSIDASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: A09AA02 – DCI PANCREATINUM (concentraţia 35.000 U FE) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L04AA25-SHUa – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)

Protocol terapeutic: L04AA25-HPN – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)

Protocol terapeutic: L01XE31 – DCI NINTEDANIBUM (OFEV) (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)